De Shi: iMedImage medical imaging base model covers over 90% of clinical medical imaging scenarios, and can reduce the research and development costs of specialized AI models by over 90%.

At the 10th World Growth Congress in 2026, Hangzhou Deshik Biological Technology Co., Ltd. presented its self-developed iMedImage medical imaging base model at the "Hangzhou AI Eighteen Arhats" joint exhibition area. Deshik debuted on the main board of the Hong Kong Stock Exchange on March 30, becoming the first stock of large-scale medical imaging models. As the first listed company in the Hangzhou "AI Eighteen Arhats", its public offering phase was oversubscribed by 1073 times, and its current market value exceeds HK$25 billion. At this exhibition, Deshik focused on two core products: the independently developed iMedImage medical imaging base model, and the AI AutoVision chromosomal karyotype diagnostic software built on that model.